Dr. Greg Riely on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment

Da: GRACEcast

0 0 7 anni fa

00:00

02:20

Mi piace Mi piace

Download Embed

Info
Chat in Diretta Commenti

Medicina, #advanced, #antipd1, #braf, #cancer, #cancergrace, #center, #crizotinib, #grace, #gracecast, #greg, #immunotherapy, #lung, #magea3, #memorial, #mskcc, #mutation, #riely, #ros1, #sloankettering, #xalkori

Dr. Greg Riely, Memorial Sloan-Kettering, provides his view on the targeted therapy approaches most likely to become clinically useful in lung cancer over the next several years.